The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

Improving access to transgender-friendly health care can help decrease the burden on ERs

Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are

June 18, 2023

After Gaza tweet, firing of life sciences journal editor sparks freedom of speech concerns

Pioneering life sciences journal eLife finds itself at the center of a white-hot furor after its governing board fired editor-in-chief Michael Eisen following his endorsement

October 25, 2023

Study reveals health and economic impact of air pollution in aging societies

Air pollution is a growing health issue worldwide, and its impacts are often underestimated in aging societies like Japan.

February 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.